Chronic Traumatic Encephalopathy Global Market Report 2026
상품코드:1951618
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
만성 외상성 뇌병증(CTE) 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 15억 1,000만 달러에서 2026년에는 16억 5,000만 달러로, CAGR 8.7%로 확대될 전망입니다. 지난 몇 년간 성장 요인으로는 접촉 스포츠 참여 증가, 두부 외상에 대한 인식 개선, 신경학 연구의 발전, 재향군인의 건강 관리 요구, 영상 진단 기술의 발전 등을 꼽을 수 있습니다.
만성 외상성 뇌병증(CTE) 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 22억 7,000만 달러에 달하고, CAGR은 8.4%가 될 전망입니다. 예측 기간의 성장 요인으로는 바이오마커 발견, 조기 개입 프로그램, 스포츠 안전 규제, 신경퇴행성 질환 연구 자금, 예방의학에 대한 집중을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 조기 진단에 대한 관심 증가, 신경영상 진단 및 바이오마커 조사 확대, 재활치료에 대한 강조 강화, 스포츠 관련 뇌손상에 대한 인식 개선, 다학제적 치료 접근법의 성장 등을 들 수 있습니다.
두부 외상 발생률의 증가는 향후 몇 년 동안 만성 외상성 뇌병증(CTE) 시장의 성장을 견인할 것으로 예상됩니다. 두부 외상은 외부의 충격이나 힘에 의해 두피, 두개골 또는 뇌에 물리적 손상을 입는 것을 말합니다. 두부 외상의 증가는 주로 충돌이나 사고로 인한 외상성 뇌손상의 위험을 증가시키는 고충격 스포츠 참여의 증가와 관련이 있습니다. 만성 외상성 뇌병증은 반복적인 두부 외상으로 인해 뇌에 타우 단백질이 비정상적으로 축적되는 질환입니다. 이 축적은 점차 뇌세포를 손상시켜 인지 기능 저하, 기분 장애, 행동 변화를 유발합니다. 예를 들어, 미국 정부 기관인 테네시 주 보건국에 따르면 2024년 11월 기준, 2023년 외상성 뇌손상(TBI) 등록제도에 보고 기준을 충족한 환자 수는 총 8,196명으로 2022년 대비 2.4% 증가했다고 합니다. 따라서 두부 외상의 증가 추세는 만성 외상성 뇌병증 시장의 성장을 촉진하고 있습니다.
만성 외상성 뇌병증 시장의 주요 기업들은 임상시험을 가속화하고 혁신적인 진단 및 치료 솔루션을 효율적으로 제공하기 위해 자회사를 설립하는 등 선진적인 전략에 초점을 맞추고 있습니다. 자회사는 모회사가 소유 또는 지배하는 법적 독립체로서, 보통 모회사가 과반수 지분을 보유합니다. 이 구조를 통해 모회사는 신규 시장 진출, 리스크 관리, 연구개발(R&D) 및 지역 성장과 같은 전문 분야에 집중할 수 있습니다. 예를 들어, 2023년 5월 미국 바이오테크 기업 셀라퓨틱 솔루션즈 인터내셔널은 자회사인 'CTE 바이오로직스'를 설립하여 자디셀 범용 성인 줄기세포를 이용한 CTE 치료에 대한 임상 데이터 및 임상시험계획(IND)의 상용화를 목표로 하고 있습니다. 설립하였습니다. 이 자회사는 운동선수와 퇴역군인에게 많이 나타나는 신경퇴행성 질환인 CTE에 대한 자디셀 기반 치료제 개발에 전념하고 있으며, 기존 임상 데이터와 FDA의 지속적인 규제 대응을 활용하여 현재 치료제가 없는 이 질환에 대한 공식적인 임상시험 개시를 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Chronic traumatic encephalopathy (CTE) is a brain disorder caused by repeated head injuries over time. It can affect memory, thinking, and emotional regulation, leading to confusion, mood swings, and difficulty performing daily tasks, often appearing years after the initial trauma.
The main types of CTE treatment include pharmacological treatments, rehabilitation therapies, psychological support, surgical interventions, and alternative therapies. Pharmacological treatments involve medications such as anti-inflammatory drugs and antidepressants to manage symptoms, reduce brain inflammation, and improve daily functioning. Diagnosis uses tools such as imaging tests, neurological exams, and biomarker tests. Treatments are applied for early-stage and advanced-stage CTE and are utilized by end-users including hospitals, clinics, research institutes, and others.
Tariffs have influenced the chronic traumatic encephalopathy market by raising costs for neuroimaging equipment, biomarker testing kits, and neuroprotective drugs. Diagnostic and pharmacological treatment segments are most affected, especially in North America and Europe where advanced neurological technologies are imported. Research institutes also face higher costs for testing and trials. On the positive side, tariffs are encouraging local manufacturing of diagnostic tools and neurological therapeutics.
The chronic traumatic encephalopathy market research report is one of a series of new reports from The Business Research Company that provides chronic traumatic encephalopathy market statistics, including chronic traumatic encephalopathy industry global market size, regional shares, competitors with a chronic traumatic encephalopathy market share, detailed chronic traumatic encephalopathy market segments, market trends and opportunities, and any further data you may need to thrive in the chronic traumatic encephalopathy industry. This chronic traumatic encephalopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The chronic traumatic encephalopathy market size has grown strongly in recent years. It will grow from $1.51 billion in 2025 to $1.65 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to contact sports participation, head injury awareness, neurology research growth, veteran healthcare needs, imaging advancements.
The chronic traumatic encephalopathy market size is expected to see strong growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to biomarker discovery, early intervention programs, sports safety regulations, neurodegenerative research funding, preventive care focus. Major trends in the forecast period include growing focus on early diagnosis, expansion of neuroimaging and biomarker research, increased emphasis on rehabilitation therapies, rising awareness of sports-related brain injuries, growth of multidisciplinary treatment approaches.
The rising incidence of head injuries is expected to drive the growth of the chronic traumatic encephalopathy (CTE) market in the coming years. Head injuries refer to physical trauma to the scalp, skull, or brain caused by external impacts or forces. The increasing number of head injuries is primarily linked to greater participation in high-impact sports, which raises the risk of traumatic brain injuries from collisions and accidents. Chronic traumatic encephalopathy develops from repeated head injuries, leading to the abnormal accumulation of tau protein in the brain. This buildup gradually damages brain cells, causing cognitive decline, mood disturbances, and behavioral changes. For instance, in November 2024, according to the Tennessee Department of Health, a US-based government agency, a total of 8,196 patients met the criteria for reporting to the traumatic brain injury (TBI) registry in 2023, marking a 2.4% increase compared to 2022. Therefore, the rising prevalence of head injuries is propelling the growth of the chronic traumatic encephalopathy market.
Major companies in the chronic traumatic encephalopathy market are focusing on advanced strategies, such as establishing subsidiary companies, to accelerate clinical trials and efficiently deliver innovative diagnostic and therapeutic solutions. A subsidiary company is a legally separate entity owned or controlled by a parent company, which typically holds a majority stake. This structure allows the parent company to expand into new markets, manage risk, and focus on specialized areas such as research and development (R&D) or regional growth. For instance, in May 2023, Therapeutic Solutions International, a US-based biotechnology company, launched CTE Biologics Inc., a subsidiary aimed at commercializing its clinical data and investigational new drug (IND) application for the treatment of chronic traumatic encephalopathy using JadiCell universal adult stem cells. The subsidiary is dedicated to advancing JadiCell-based therapies for CTE, a neurodegenerative condition frequently observed in athletes and military veterans, leveraging existing clinical data and ongoing regulatory interactions with the FDA to potentially initiate formal clinical trials for this currently untreatable disorder.
In March 2025, Enigma Biomedical USA Inc., a US-based biotechnology company, partnered with Boston University's chronic traumatic encephalopathy (CTE) Center and the Concussion Legacy Foundation to advance early detection of CTE through innovative imaging approaches. This collaboration focuses on validating 4R tau PET imaging biomarkers to improve understanding and early diagnosis of CTE in living patients. The Concussion Legacy Foundation (CLF) is a US-based nonprofit organization, and the Boston University CTE Center is a US-based research organization specializing in high-impact studies on chronic traumatic encephalopathy.
Major companies operating in the chronic traumatic encephalopathy market are Abbott Laboratories, Roche Diagnostics, GE HealthCare, Siemens Healthineers, Fujirebio, BioLegend, Thermo Fisher Scientific, Eisai Co. Ltd., Biogen Inc., Johnson & Johnson (Janssen Neuroscience), Eli Lilly and Company, Bristol Myers Squibb, AbbVie Inc., AC Immune SA, TauRx Therapeutics Ltd., Ionis Pharmaceuticals, Alector Inc., Cortexyme Inc., BrainScope Company Inc., BrainCheck Inc., NeuroTrax Corporation, Banyan Biomarkers Inc., ImPACT Applications Inc., CNS Vital Signs LLC, Neural Analytics Inc., MindMaze SA, ReWalk Robotics Ltd., Neuronetics Inc., Abbott Neuromodulation, Medtronic plc, Abbott Laboratories Diagnostics, Philips Healthcare, Canon Medical Systems, Bruker Corporation, PerkinElmer Inc., Sutter Health Neuroscience Institute, Cleveland Clinic, Johns Hopkins Medicine, Mount Sinai Health System, Barrow Neurological Institute, Shepherd Center, Spaulding Rehabilitation Network, Kessler Foundation, Shirley Ryan AbilityLab, TBI Care Foundation.
North America was the largest region in the chronic traumatic encephalopathy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic traumatic encephalopathy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the chronic traumatic encephalopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic traumatic encephalopathy market consists of revenues earned by entities by providing services such as personalized medicine planning, telemedicine, genetic testing, occupational therapy, mental health support, cognitive therapy, and patient monitoring. The market value includes the value of related products and medical devices sold by the service providers or included within the service offering. The chronic traumatic encephalopathy market also includes sales of wearable health monitoring devices, brain imaging equipment, neuroprotective supplements, and biomarker assay kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Traumatic Encephalopathy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses chronic traumatic encephalopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chronic traumatic encephalopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic traumatic encephalopathy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Treatment: Pharmacological Treatments; Rehabilitation Therapies; Psychological Support; Surgical Interventions; Alternative Therapies
2) By Diagnosis Type: Imaging Tests; Neurological Exams; Biomarker Tests; Other Diagnosis Types
3) By Disease Type: Early Stage Chronic Traumatic Encephalopathy (CTE); Advanced Stage Chronic Traumatic Encephalopathy (CTE)
4) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.2 Expansion Of Neuroimaging And Biomarker Research
4.2.3 Increased Emphasis On Rehabilitation Therapies
4.2.4 Rising Awareness Of Sports-Related Brain Injuries
4.2.5 Growth Of Multidisciplinary Treatment Approaches
5. Chronic Traumatic Encephalopathy Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Research Institutes
5.4 Rehabilitation Centers
5.5 Sports Medicine Centers
6. Chronic Traumatic Encephalopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Chronic Traumatic Encephalopathy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Chronic Traumatic Encephalopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Chronic Traumatic Encephalopathy Market Size, Comparisons And Growth Rate Analysis
7.3. Global Chronic Traumatic Encephalopathy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Chronic Traumatic Encephalopathy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Chronic Traumatic Encephalopathy Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.4. Global Chronic Traumatic Encephalopathy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Research Institutes, Other End-Users
9.5. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Pharmacological Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Rehabilitation Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Psychological Support, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cognitive Behavioral Therapy (CBT), Support Groups, Counseling Services, Stress Management Programs, Psychiatric Care
9.8. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Surgical Interventions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Decompressive Surgery, Ventriculoperitoneal Shunt, Deep Brain Stimulation (DBS), Neuroendoscopy
9.9. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Alternative Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Acupuncture, Herbal Medicine, Meditation And Mindfulness, Nutritional Therapy, Chiropractic Treatment
10. Chronic Traumatic Encephalopathy Market Regional And Country Analysis
10.1. Global Chronic Traumatic Encephalopathy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Chronic Traumatic Encephalopathy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Chronic Traumatic Encephalopathy Market
12.1. China Chronic Traumatic Encephalopathy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Chronic Traumatic Encephalopathy Market
13.1. India Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Chronic Traumatic Encephalopathy Market
14.1. Japan Chronic Traumatic Encephalopathy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Chronic Traumatic Encephalopathy Market
15.1. Australia Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Chronic Traumatic Encephalopathy Market
16.1. Indonesia Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Chronic Traumatic Encephalopathy Market
17.1. South Korea Chronic Traumatic Encephalopathy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Chronic Traumatic Encephalopathy Market
19.1. South East Asia Chronic Traumatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Chronic Traumatic Encephalopathy Market
20.1. Western Europe Chronic Traumatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Chronic Traumatic Encephalopathy Market
21.1. UK Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Chronic Traumatic Encephalopathy Market
23.1. France Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Chronic Traumatic Encephalopathy Market
24.1. Italy Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Chronic Traumatic Encephalopathy Market
25.1. Spain Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Chronic Traumatic Encephalopathy Market
26.1. Eastern Europe Chronic Traumatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Chronic Traumatic Encephalopathy Market
27.1. Russia Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Chronic Traumatic Encephalopathy Market
28.1. North America Chronic Traumatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Chronic Traumatic Encephalopathy Market
29.1. USA Chronic Traumatic Encephalopathy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Chronic Traumatic Encephalopathy Market
31.1. South America Chronic Traumatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Chronic Traumatic Encephalopathy Market
32.1. Brazil Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Chronic Traumatic Encephalopathy Market
33.1. Middle East Chronic Traumatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Chronic Traumatic Encephalopathy Market
34.1. Africa Chronic Traumatic Encephalopathy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Segmentation By Diagnosis Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Chronic Traumatic Encephalopathy Market Regulatory and Investment Landscape
36. Chronic Traumatic Encephalopathy Market Competitive Landscape And Company Profiles
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Chronic Traumatic Encephalopathy Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Chronic Traumatic Encephalopathy Market Company Profiles
36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
36.3.3. GE HealthCare Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Fujirebio Overview, Products and Services, Strategy and Financial Analysis
37. Chronic Traumatic Encephalopathy Market Other Major And Innovative Companies
BioLegend, Thermo Fisher Scientific, Eisai Co. Ltd., Biogen Inc., Johnson & Johnson (Janssen Neuroscience), Eli Lilly and Company, Bristol Myers Squibb, AbbVie Inc., AC Immune SA, TauRx Therapeutics Ltd., Ionis Pharmaceuticals, Alector Inc., Cortexyme Inc., BrainScope Company Inc., BrainCheck Inc.
38. Global Chronic Traumatic Encephalopathy Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Chronic Traumatic Encephalopathy Market
40. Chronic Traumatic Encephalopathy Market High Potential Countries, Segments and Strategies
40.1 Chronic Traumatic Encephalopathy Market In 2030 - Countries Offering Most New Opportunities
40.2 Chronic Traumatic Encephalopathy Market In 2030 - Segments Offering Most New Opportunities
40.3 Chronic Traumatic Encephalopathy Market In 2030 - Growth Strategies
